Standard Life Aberdeen has continued to buy back shares from investors following the sale of its life arm to Phoenix last year.
A stock exchange announcement this morning shows it purchased 962,182 ordinary shares yesterday (11 February) at an average 247p.
This follows daily transactions since the announcement last summer for a £175m first tranche of the share buyback programme.
The first tranche was completed in November and resulted in the repurchase and cancellation of 58,585,389 ordinary shares for a total of £174,999,998.
A further tranche of £200m of the repurchase scheme began on 20 November and is expected to end no later than 27 March.
The company has suffered outflows since forming through merger in 2017. Lloyds cancelled a mandate run for Scottish Widows by Aberdeen because it felt the addition of Standard Life could turn the new firm into a competitor.
Part of the mandate went to Schroders who announced a joint “strategic partnership” with Scotish Widows parent Lloyds for at least five years.